Inventor
VLASSOV ALEXANDER
US14 patents
⚠️ This page may combine multiple inventors who share the name “VLASSOV ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIFE TECHNOLOGIES CORP
7 patentsUS8901284B2Dec 2, 2014
Methods and compositions for exosome isolation
LIFE TECHNOLOGIES CORP23 citations91
US9347087B2May 24, 2016
Methods and compositions for exosome isolation
LIFE TECHNOLOGIES CORP9 citations82
US9671321B2Jun 6, 2017
Methods and compositions for exosome isolation
LIFE TECHNOLOGIES CORP3 citations71
US9410153B2Aug 9, 2016
Compositions and methods for inhibition of nucleic acids function
LIFE TECHNOLOGIES CORP2 citations61
US10023866B2Jul 17, 2018
Compositions and methods for inhibition of nucleic acids function
LIFE TECHNOLOGIES CORP0 citations50
US9783804B2Oct 10, 2017
Compositions and methods for inhibition of nucleic acids function
LIFE TECHNOLOGIES CORP0 citations50
US10731146B2Aug 4, 2020
Purification of nucleic acid from environmental or biological samples
LIFE TECHNOLOGIES CORP0 citations45
APPLIED BIOSYSTEMS LLC
4 patentsUS9273312B2Mar 1, 2016
SiRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof
APPLIED BIOSYSTEMS LLC5 citations82
US9771583B2Sep 26, 2017
siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAI, and stabilized forms thereof
APPLIED BIOSYSTEMS LLC2 citations71
US10329564B2Jun 25, 2019
siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof
APPLIED BIOSYSTEMS LLC1 citations69
US10900038B2Jan 26, 2021
siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAI, and stabilized forms thereof
APPLIED BIOSYSTEMS LLC0 citations59